Search Results - "Koster, M. P. H."

Parental perspectives on the awareness and delivery of preconception care by Poels, M, Koster, M P H, Franx, A, van Stel, H F

“…The attention for Preconception Care (PCC) has grown substantially in recent years, yet the implementation of PCC appears challenging as uptake rates remain…”
Get full text

Human fetal growth is constrained below optimal for perinatal survival by Vasak, B., Koenen, S. V., Koster, M. P. H., Hukkelhoven, C. W. P. M., Franx, A., Hanson, M. A., Visser, G. H. A.

“…ABSTRACT Objective The use of fetal growth charts assumes that the optimal size at birth is at the 50th birth‐weight centile, but interaction between maternal…”
Get full text

The effect of a locally tailored intervention on the uptake of preconception care in the Netherlands: a stepped-wedge cluster randomized trial (APROPOS-II study) by Maas, V.Y.F, Poels, M, Ista, E, Menge, L.F, Vanden Auweele, K.L.H.E, de Bie, R.W.A, de Smit, D. J, van Vliet-Lachotzki, E.H, Franx, A, Koster, M.P.H

“…Abstract Background The preconception period provides a window of opportunity for interventions aiming to reduce unhealthy lifestyle behaviours and their…”
Get full text

First‐trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early‐onset pre‐eclampsia by Wortelboer, EJ, Koster, MPH, Cuckle, HS, Stoutenbeek, Ph, Schielen, PCJI, Visser, GHA

“…Please cite this paper as: Wortelboer E, Koster M, Cuckle H, Stoutenbeek P, Schielen P, Visser G. First‐trimester placental protein 13 and placental growth…”
Get full text

Modeling Down syndrome screening performance using first‐trimester serum markers by Koster, M. P. H., Wortelboer, E. J., Stoutenbeek, P., Visser, G. H. A., Schielen, P. C. J. I.

“…Objective To evaluate the modeled predictive value of three current screening markers (pregnancy‐associated plasma protein‐A (PAPP‐A), free β‐human chorionic…”
Get full text

Longitudinal trends in fetoplacental biochemical markers, uterine artery pulsatility index and maternal blood pressure during the first trimester of pregnancy by Wortelboer, E. J., Koster, M. P. H., Kuc, S., Eijkemans, M. J. C., Bilardo, C. M., Schielen, P. C. J. I., Visser, G. H. A.

“…Objective To assess trends in levels of biochemical markers, uterine artery (UtA) pulsatility index (PI) and maternal blood pressure changes over time and…”
Get full text

The physiological effect of early pregnancy on a woman’s response to a submaximal cardiopulmonary exercise test by Bijl, Rianne C., Cornette, Jérôme M. J., Ham, Kim, Zwart, Merle L., Dos Reis Miranda, Dinis, Steegers‐Theunissen, Régine P. M., Franx, Arie, Molinger, Jeroen, Koster, M. P. H. (Wendy)

“…Given all its systemic adaptive requirements, pregnancy shares several features with physical exercise. In this pilot study, we aimed to assess the…”
Get full text

Quality of nuchal translucency measurements in The Netherlands: a quantitative analysis by Koster, M. P. H., Wortelboer, E. J., Engels, M. A. J., Stoutenbeek, P. H., Elvers, L. H., Visser, G. H. A., Schielen, P. C. J. I.

“…Objective The Dutch Centre for Population Research has specified quality demands for nuchal translucency (NT) measurement in The Netherlands. We performed an…”
Get full text

Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening by Koster, M. P. H., Pennings, J. L. A., Imholz, S., Rodenburg, W., Visser, G. H. A., de Vries, A., Schielen, P. C. J. I.

“…Objectives To identify new discriminative biomarkers for Down syndrome (DS) pregnancies using a bead‐based multiplexed immunoassay, and to use the newly…”
Get full text

Performance of first-trimester serum screening for trisomy 21 before and from 11 + 0 weeks of gestational age in The Netherlands by Kuc, S., Koster, M. P. H., Visser, G. H. A., Schielen, P. C. J. I.

Get full text

First-trimester Down syndrome screening performance in the Dutch population; how to achieve further improvement? by Wortelboer, E. J., Koster, M. P. H., Stoutenbeek, Ph, Elvers, L. H., Loeber, J. G., Visser, G. H. A., Schielen, P. C. J. I.

“…Objective To study the performance of the first‐trimester combined test between 2004 and 2006 compared to a previous period to investigate changes in time and…”
Get full text

Proteomics and Down syndrome screening: a validation study by Koster, M. P. H., Pennings, J. L. A., Imholz, S., Rodenburg, W., Visser, G. H. A., de Vries, A., Schielen, P. C. J. I.

“…Objective In a previous discovery study, we identified seven potential screening markers for Down syndrome (DS). Here, we report on an extended study to…”
Get full text

ADAM12s as a first-trimester screening marker of trisomy by Wortelboer, E. J., Linskens, I. H., Koster, M. P. H., Stoutenbeek, P., Cuckle, H., Blankenstein, M. A., Visser, G. H. A., van Vugt, J. M. G., Schielen, P. C. J. I.

“…Objective To evaluate the potential of maternal serum A Disintegrin And Metalloprotease 12‐S (ADAM12s) as an additional marker for the combined test in the…”
Get full text

Distributions of current and new first-trimester Down syndrome screening markers in twin pregnancies by Koster, M. P. H., Wortelboer, E. J., Stoutenbeek, Ph, Visser, G. H. A., Schielen, P. C. J. I.

“…Objectives To study the distributions of pregnancy‐associated plasma protein A (PAPP‐A), the free β subunit of human chorion gonadotrophin (fβ‐hCG), A…”
Get full text

Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features by Daan, N.M.P., Jaspers, L., Koster, M.P.H., Broekmans, F.J.M., de Rijke, Y.B., Franco, O.H., Laven, J.S.E., Kavousi, M., Fauser, B.C.J.M.

“…STUDY QUESTION Are differences in androgen levels among women with various forms of ovarian dysfunction associated with cardiometabolic abnormalities? SUMMARY…”
Get full text

Trisomy 18 and 13 screening: consequences for the Dutch Down syndrome screening programme by Koster, M. P. H., Stoutenbeek, P., Visser, G. H. A., Schielen, P. C. J. I.

Get full text

Lack of standardization in determining gestational age for prenatal screening by Koster, M. P. H., Van Leeuwen‐Spruijt, M., Wortelboer, E. J., Stoutenbeek, P., Elvers, L. H., Loeber, J. G., Visser, G. H. A., Schielen, P. C. J. I.

“…Objectives To determine whether estimation of gestational age (GA) in the context of first‐trimester Down syndrome screening is standardized in the…”
Get full text

First-trimester utero-placental (vascular) development and embryonic and fetal growth: The Rotterdam periconception cohort by Reijnders, I.F., Mulders, A.G.M.G.J., Koster, M.P.H., Kropman, A.T.M., de Vos, E.S., Koning, A.H.J., Willemsen, S.P., Rousian, M., Steegers, E.A.P., Steegers-Theunissen, R.P.M.

“…Impaired placental development is a major cause of fetal growth restriction (FGR) and early detection will therefore improve antenatal care and birth outcomes…”
Get full text

Fifteen years of triple tests in The Netherlands; the life cycle of a screening test by Wortelboer, E. J., Koster, M. P. H., Stoutenbeek, Ph, Loeber, J. G., Visser, G. H. A., Schielen, P. C. J. I.

“…Objective This report provides an overview of 15 years prenatal screening for Down syndrome (DS). Methods Between 1991 and 2005, blood samples for the triple…”
Get full text

Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome by de Wilde, M.A., Veltman-Verhulst, S.M., Goverde, A.J., Lambalk, C.B., Laven, J.S.E., Franx, A., Koster, M.P.H., Eijkemans, M.J.C., Fauser, B.C.J.M.

“…STUDY QUESTION Can we develop an adequate preconception prediction model to identify those women with polycystic ovary syndrome (PCOS) who have an increased…”
Get full text